Competitive Technologies, Inc. (CTCC) Announces Results of Pilot Trials Using Calmare(R) Medical Device With "Scrambler Therapy"(TM) Technology
5/18/2012 9:44:31 AM
FAIRFIELD, Conn., May 18, 2012 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) announced today the availability of two clinical trial abstracts announced by the American Society of Clinical Oncology (ASCO). Both abstracts indicate positive effects from the use of the Calmare® medical device with "Scrambler Therapy"™ technology. One study is on patients suffering from chemotherapy-induced peripheral neuropathy (CIPN) and the other is on patients suffering from post-herpetic neuropathy (PHN).
comments powered by